Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 384

1.

Effects of everolimus as an antiproliferative agent on regression of encapsulating peritoneal sclerosis in a rat model.

Duman S, Bozkurt D, Sipahi S, Sezak M, Ozkan S, Ertilav M, Sen S, Ok E.

Adv Perit Dial. 2008;24:104-10.

PMID:
18986012
2.
3.

Can N-acetylcysteine preserve peritoneal function and morphology in encapsulating peritoneal sclerosis?

Bozkurt D, Hur E, Ulkuden B, Sezak M, Nar H, Purclutepe O, Sen S, Duman S.

Perit Dial Int. 2009 Feb;29 Suppl 2:S202-5.

PMID:
19270218
4.

Does immunosuppressive treatment ameliorate morphology changes in encapsulating peritoneal sclerosis?

Bozkurt D, Sipahi S, Cetin P, Hur E, Ozdemir O, Ertilav M, Sen S, Duman S.

Perit Dial Int. 2009 Feb;29 Suppl 2:S206-10.

PMID:
19270219
5.

The effects of renin-angiotensin system inhibition on regression of encapsulating peritoneal sclerosis.

Bozkurt D, Cetin P, Sipahi S, Hur E, Nar H, Ertilav M, Sezak M, Duman S.

Perit Dial Int. 2008 Nov;28 Suppl 5:S38-42. Erratum in: Perit Dial Int. 2009 Mar-Apr;29(2):131-2.

PMID:
19008539
6.

The effects of colchicine on the progression and regression of encapsulating peritoneal sclerosis.

Bozkurt D, Bicak S, Sipahi S, Taskin H, Hur E, Ertilav M, Sen S, Duman S.

Perit Dial Int. 2008 Nov;28 Suppl 5:S53-7. Erratum in: Perit Dial Int. 2009 Mar-Apr;29(2):131-2.

PMID:
19008543
7.

Effect of sirolimus on the regression of peritoneal sclerosis in an experimental rat model.

Ceri M, Unverdi S, Dogan M, Unverdi H, Karaca G, Kocak G, Kurultak I, Akbal E, Can M, Duranay M.

Int Urol Nephrol. 2012 Jun;44(3):977-82. doi: 10.1007/s11255-012-0167-3. Epub 2012 Apr 15.

PMID:
22528580
8.

Does enalapril prevent peritoneal fibrosis induced by hypertonic (3.86%) peritoneal dialysis solution?

Duman S, Günal AI, Sen S, Asçi G, Ozkahya M, Terzioglu E, Akçiçek F, Atabay G.

Perit Dial Int. 2001 Mar-Apr;21(2):219-24.

PMID:
11330572
9.

Atorvastatin improves peritoneal sclerosis induced by hypertonic PD solution in rats.

Duman S, Sen S, Sozmen EY, Oreopoulos DG.

Int J Artif Organs. 2005 Feb;28(2):170-6.

PMID:
15770605
10.

Effect of valsartan versus lisinopril on peritoneal sclerosis in rats.

Duman S, Sen S, Duman C, Oreopoulos DG.

Int J Artif Organs. 2005 Feb;28(2):156-63.

PMID:
15770604
11.
12.

Role of tyrosine kinase inhibition with imatinib in an encapsulating peritoneal sclerosis rat model.

Velioglu A, Tugtepe H, Asicioglu E, Yilmaz N, Filinte D, Arikan H, Koc M, Tuglular S, Kaya H, Ozener C.

Ren Fail. 2013;35(4):531-7. doi: 10.3109/0886022X.2013.773915. Epub 2013 Mar 11.

PMID:
23473055
13.

Octreotide lessens peritoneal injury in experimental encapsulated peritoneal sclerosis model.

Ertilav M, Hur E, Bozkurt D, Sipahi S, Timur O, Sarsik B, Akcicek F, Duman S.

Nephrology (Carlton). 2011 Aug;16(6):552-7. doi: 10.1111/j.1440-1797.2011.01460.x.

PMID:
21382127
14.

Effect of glucose degradation products on the peritoneal membrane in a chronic inflammatory infusion model of peritoneal dialysis in the rat.

Park SH, Lee EG, Kim IS, Kim YJ, Cho DK, Kim YL.

Perit Dial Int. 2004 Mar-Apr;24(2):115-22.

PMID:
15119632
15.

The effect of oxidative stress inhibition with trimetazidine on the peritoneal alterations induced by hypertonic peritoneal dialysis solution.

Günal AI, Celiker H, Ustundag B, Akpolat N, Dogukan A, Akcicek F.

J Nephrol. 2003 Mar-Apr;16(2):225-30.

PMID:
12768069
16.

Development of a peritoneal sclerosis rat model using a continuous-infusion pump.

Komatsu H, Uchiyama K, Tsuchida M, Isoyama N, Matsumura M, Hara T, Fukuda M, Kanaoka Y, Naito K.

Perit Dial Int. 2008 Nov-Dec;28(6):641-7.

PMID:
18981396
17.

Peritoneal morphologic changes in a peritoneal dialysis rat model correlate with angiopoietin/Tie-2.

Yuan J, Fang W, Ni Z, Dai H, Lin A, Cao L, Qian J.

Pediatr Nephrol. 2009 Jan;24(1):163-70. doi: 10.1007/s00467-008-0944-5. Epub 2008 Aug 28.

PMID:
18751736
18.

Risk factors for encapsulating peritoneal sclerosis in patients who have experienced peritoneal dialysis treatment.

Yamamoto R, Otsuka Y, Nakayama M, Maruyama Y, Katoh N, Ikeda M, Yamamoto H, Yokoyama K, Kawaguchi Y, Matsushima M.

Clin Exp Nephrol. 2005 Jun;9(2):148-52.

PMID:
15980950
19.
20.

New animal models for encapsulating peritoneal sclerosis--role of acidic solution.

Nakamoto H, Imai H, Ishida Y, Yamanouchi Y, Inoue T, Okada H, Suzuki H.

Perit Dial Int. 2001;21 Suppl 3:S349-53.

PMID:
11887851

Supplemental Content

Support Center